Generalized Urticaria and Decreased Consciousness After Barbecue

  • Taher CheraghiEmail author

Practical Points

  • When no suspected allergen exists or the patients is not identified as being allergic to the exposed substance, the diagnosis of anaphylaxis is based on mucocutanous manifestations and at least one of the respiratory or cardiovascular systems

  • When there is a history of exposure to a likely/common allergen, the diagnosis is confirmed by involvement of two of the cutaneous, respiratory, cardiovascular, and gastrointestinal systems

  • Following exposure to a known allergen for that patient a decrease in blood pressure (hypotension) is enough to start treatment

  • Intravenous fluids, antihistamines, glucocorticoids and inhaled short-acting beta agonists, as well as high flow oxygen are second-line options for management of an anaphylactic reaction

  • Previous use of beta blockers, angiotensin converting enzyme inhibitors, or non-steroidal anti-inflammatory drugs report of a more severe anaphylactic attack

  • Provide the patient with anaphylactic attack with an autoinjector epinephrine and refer him/her to an allergist upon discharge from emergency department


Anaphylaxis Tryptase Angiotensin-converting enzyme inhibitors 


  1. 1.
    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O’Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391–7.CrossRefGoogle Scholar
  2. 2.
    Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, Ellis A, Golden DB, Greenberger P, Kemp S, Khan D, Ledford D, Lieberman J, Metcalfe D, Nowak-Wegrzyn A, Sicherer S, Wallace D, Blessing-Moore J, Lang D, Portnoy JM, Schuller D, Spector S, Tilles SA. Anaphylaxis--a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341–84.CrossRefGoogle Scholar
  3. 3.
    Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, Cardona V, Dubois A, duToit G, Eigenmann P, Fernandez Rivas M, Halken S, Hickstein L, Host A, Knol E, Lack G, Marchisotto MJ, Niggemann B, Nwaru BI, Papadopoulos NG, Poulsen LK, Santos AF, Skypala I, Schoepfer A, Van Ree R, Venter C, Worm M, Vlieg-Boerstra B, Panesar S, de Silva D, Soares-Weiser K, Sheikh A, Ballmer-Weber BK, Nilsson C, de Jong NW, Akdis CA. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008–25.CrossRefGoogle Scholar
  4. 4.
    Simons FE, Ardusso LR, Bilo MB, Cardona V, Ebisawa M, El-Gamal YM, Lieberman P, Lockey RF, Muraro A, Roberts G, Sanchez-Borges M, Sheikh A, Shek LP, Wallace DV, Worm M. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7(1):9.CrossRefGoogle Scholar
  5. 5.
    Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, Lockey RF, El-Gamal YM, Brown SG, Park HS, Sheikh A. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8(1):32.CrossRefGoogle Scholar
  6. 6.
    Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 2017;140(2):335–48.CrossRefGoogle Scholar
  7. 7.
    Stelle F, Simons R. Anaphylaxis: assessment and management. In: Leung Donald YM, Szefler SJ, Bonilla FA, Akdis CA, Sampson HA, editors. Pediatric Allergy, Principles and Practice. 3rd ed. Amsterdam: Elsevier; 2016.Google Scholar
  8. 8.
    Brown SGA. Anaphylaxis. In: Adkinson F, et al., editors. Middleton’s allergy principles and practice. 8th ed. Amsterdam: Elsevier; 2013.Google Scholar
  9. 9.
    Craig T, Pursun EA, Bork K, Bowen T, Boysen H, Farkas H, Grumach A, Katelaris CH, Lockey R, Longhurst H, Lumry W, Magerl M, Martinez-Saguer I, Ritchie B, Nast A, Pawankar R, Zuraw B, Maurer M. [WAO guideline for the management of hereditary angioedema]. Arerugi. 2015;64(9):1215–1241.Google Scholar
  10. 10.
    Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, Santos AF, Zolkipli ZQ, Bellou A, Beyer K, Bindslev-Jensen C, Cardona V, Clark AT, Demoly P, Dubois AEJ, DunnGalvin A, Eigenmann P, Halken S, Harada L, Lack G, Jutel M, Niggemann B, Ruëff F, Timmermans F, Vlieg-Boerstra BJ, Werfel T, Dhami S, Panesar S, Akdis CA, Sheikh A, the EFA, Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–45.CrossRefGoogle Scholar
  11. 11.
    Peters SP. Asthma phenotypes: nonallergic (intrinsic) asthma. J Allergy Clin Immunol Pract. 2014;2(6):650–2.CrossRefGoogle Scholar
  12. 12.
    Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract. 2014;2(6):645–8; quiz 9.CrossRefGoogle Scholar
  13. 13.
    Campbell RL, Kelso JM, Walls RM, Randolph AG, Feldweg AM. Anaphylaxis: emergency treatment; 2018.
  14. 14.
    Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414–20.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pediatrics, 17th Shahrivar Children’s Hospital, School of MedicineGuilan University of Medical SciencesRashtIran

Personalised recommendations